Skip to main content
Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis

Dr. Mike Putman discusses abstract 0670, presented

Dr. John Cush RheumNow

1 year 10 months ago
Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis Dr. Mike Putman discusses abstract 0670, presented at #ACR24. https://t.co/aLzsSSOmML https://t.co/XrEtNZAgHI
SELECTing the right patients: upadacitinib in GCA

Dr. Brian Jaros reports on abstract 1695, presented at #ACR24.

http

Dr. John Cush RheumNow

1 year 10 months ago
SELECTing the right patients: upadacitinib in GCA Dr. Brian Jaros reports on abstract 1695, presented at #ACR24. https://t.co/x8lLTviOKk https://t.co/yXwwrdgIyu
PsA Ultrasound Updates

Dr. Catherine Bakewell and Dr. Lihi Eder discuss updates on ultrasound in psoriatic arthritis a

Dr. John Cush RheumNow

1 year 10 months ago
PsA Ultrasound Updates Dr. Catherine Bakewell and Dr. Lihi Eder discuss updates on ultrasound in psoriatic arthritis at #ACR24. https://t.co/DZBe8uNpJS https://t.co/wIS1hUZnAS
#ACR Best 2024 - Day 4

Although the last day of #ACR24 was but a half day - it was chock full of gems, many coming fro

Dr. John Cush RheumNow

1 year 10 months ago
#ACR Best 2024 - Day 4 Although the last day of #ACR24 was but a half day - it was chock full of gems, many coming from the late breaking abstracts presented today. As chosen by the RheumNow faculty, here are some highlight presentations you need to know about.… https://t.co/ws9BOxkZft https://t.co/trMevuvvyX
Methotrexate to Prevent RA, Clear as Mud

Intervention in individuals predisposed to rheumatoid arthritis (RA), aiming

Dr. John Cush RheumNow

1 year 10 months ago
Methotrexate to Prevent RA, Clear as Mud Intervention in individuals predisposed to rheumatoid arthritis (RA), aiming for prevention, is a significant topic. Seropositivity for rheumatoid factor and ACPA can precede RA by years. Some patients experience a pre-RA arthralgia… https://t.co/D51CoZAzce https://t.co/lgZalnDeb3
Predicting flares in rheumatic diseases with machine learning

Rheumatic diseases, such as axial spondyloarthritis (axS

Dr. John Cush RheumNow

1 year 10 months ago
Predicting flares in rheumatic diseases with machine learning Rheumatic diseases, such as axial spondyloarthritis (axSpA) and rheumatoid arthritis (RA), are marked by unpredictable disease flares that adversely impact quality of life and long-term outcomes.… https://t.co/6oFRp0zyBw https://t.co/fcMrJOg4mM
Changing Mindsets about Methotrexate Side Effects

Dr. Mrinalini Dey discusses abstract 1676, presented at #ACR24.

htt

Dr. John Cush RheumNow

1 year 10 months ago
Changing Mindsets about Methotrexate Side Effects Dr. Mrinalini Dey discusses abstract 1676, presented at #ACR24. https://t.co/8RXBWUioee https://t.co/liQ1hN4Xtr
How New Medications are Reframing Imaging Abnormalities in axSpA

Bimekizumab (BKZ), a monoclonal antibody targeting IL

Dr. John Cush RheumNow

1 year 10 months ago
How New Medications are Reframing Imaging Abnormalities in axSpA Bimekizumab (BKZ), a monoclonal antibody targeting IL-17A and IL-17F, was evaluated in the BE MOBILE 1 and 2 trials for non-radiographic and radiographic axSpA, respectively. It showed significant clinical… https://t.co/wJYh5XCVfw https://t.co/qZ2MnGVXXG
Capillaroscopy is a non-invasive imaging technique used for the in vivo assessment of the microcirculation. kin capillaries at the nailfold are evaluated because the fingers are involved in pathological processes such as Raynaud’s phenomenon. Several abstracts and sessions on nailfold capillaroscopy were presented during ACR24.
In 1950, three scientists were awarded the Nobel Prize for their groundbreaking discovery of steroids, heralded at the time as a "miracle cure" for rheumatoid arthritis (RA). However, just a year after their introduction, evidence began to surface regarding the harmful side effects and withdrawal symptoms such as pain and fatigue that were independent of RA itself.
Where there’s smoke, there’s flare: how pollution fuels RA

The WHO has declared climate change to be the greatest t

Dr. John Cush RheumNow

1 year 10 months ago
Where there’s smoke, there’s flare: how pollution fuels RA The WHO has declared climate change to be the greatest threat to human health in the 21st century, likely to contribute to an additional 250,000 deaths annually between 2030 and 2050 #ACR24 https://t.co/efVzSHXN91 https://t.co/AxRyGpqQFa
Say Goodbye to Methotrexate in PMR?

Despite mixed results on its clinical efficacy in three previous randomised contro

Dr. John Cush RheumNow

1 year 10 months ago
Say Goodbye to Methotrexate in PMR? Despite mixed results on its clinical efficacy in three previous randomised controlled trials (RCTs)1-3, methotrexate is considered the most widely used GC sparing agent. #ACR24 https://t.co/x662FbdNoR https://t.co/uvMPHpmRHZ
×